test

David Kim

@Paradigm Biocapital Advisors Lp

Latest period2024 - Q3ReportedManaged Assets$2.956BTotal holdings31
Assets growth rate13.13%Assets growth rate (2-Q avg)2.56%Continuous growth in asset value1 quarters

Portfolio positions

This chart displays the top 10 holdings in Paradigm Biocapital Advisors Lp's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 31 positions.

Assets under management

The assets under management (AUM) of Paradigm Biocapital Advisors Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 2.956B in assets, with a quarterly growth rate of 13.13% and a 2-quarter average growth rate of 2.56%. The portfolio is managed by David Kim, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
SRPTSarepta Therapeutics Inc
Recent Activity
Exited
0%
$149.717M
947,574 shares@ $158.0 avg price
CERECerevel Therapeutics Hldng I
Recent Activity
Exited
0%
$95.294M
2.331M shares@ $40.89 avg price
ASNDAscendis Pharma A S
Recent Activity
Exited
0%
$90.598M
664,307 shares@ $136.39 avg price
XENEXenon Pharmaceuticals Inc
Recent Activity
Exited
0%
$79.667M
2.043M shares@ $38.99 avg price
LEGNLegend Biotech Corp
Recent Activity
Exited
0%
$53.295M
1.203M shares@ $44.29 avg price
BBIOBridgebio Pharma Inc
Recent Activity
Exited
0%
$27.597M
1.089M shares@ $25.33 avg price
VRNAVerona Pharma Plc
Recent Activity
Exited
0%
$10.427M
721,087 shares@ $14.46 avg price
ALXOAlx Oncology Hldgs Inc
Recent Activity
Exited
0%
$9.501M
1.576M shares@ $6.03 avg price
VORVor Biopharma Inc
Recent Activity
Exited
0%
$6.457M
6.457M shares@ $1.0 avg price
ACRVAcrivon Therapeutics Inc
Recent Activity
Exited
0%
$3.826M
659,724 shares@ $5.8 avg price